Literature DB >> 18222990

OPA1 mutations and mitochondrial DNA damage: keeping the magic circle in shape.

Massimo Zeviani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18222990     DOI： 10.1093/brain/awm339

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  16 in total

1.  Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion.

Authors:  Zhiyin Song; Mariam Ghochani; J Michael McCaffery; Terrence G Frey; David C Chan
Journal:  Mol Biol Cell       Date:  2009-05-28       Impact factor: 4.138

Review 2.  Multisystem manifestations of mitochondrial disorders.

Authors:  Stefano Di Donato
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

Review 3.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

4.  Subclinical multisystem neurologic disease in "pure" OPA1 autosomal dominant optic atrophy.

Authors:  M R Baker; K M Fisher; R G Whittaker; P G Griffiths; P Yu-Wai-Man; P F Chinnery
Journal:  Neurology       Date:  2011-09-14       Impact factor: 9.910

Review 5.  Neuromuscular and systemic presentations in adults: diagnoses beyond MERRF and MELAS.

Authors:  Bruce H Cohen
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

Review 6.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

7.  Encephalomyopathies caused by abnormal nuclear-mitochondrial intergenomic cross-talk.

Authors:  C Lamperti; M Zeviani
Journal:  Acta Myol       Date:  2009-07

8.  Multi-system neurological disease is common in patients with OPA1 mutations.

Authors:  P Yu-Wai-Man; P G Griffiths; G S Gorman; C M Lourenco; A F Wright; M Auer-Grumbach; A Toscano; O Musumeci; M L Valentino; L Caporali; C Lamperti; C M Tallaksen; P Duffey; J Miller; R G Whittaker; M R Baker; M J Jackson; M P Clarke; B Dhillon; B Czermin; J D Stewart; G Hudson; P Reynier; D Bonneau; W Marques; G Lenaers; R McFarland; R W Taylor; D M Turnbull; M Votruba; M Zeviani; V Carelli; L A Bindoff; R Horvath; P Amati-Bonneau; P F Chinnery
Journal:  Brain       Date:  2010-02-15       Impact factor: 13.501

9.  OPA1 mutations cause cytochrome c oxidase deficiency due to loss of wild-type mtDNA molecules.

Authors:  Patrick Yu-Wai-Man; Kamil S Sitarz; David C Samuels; Philip G Griffiths; Amy K Reeve; Laurence A Bindoff; Rita Horvath; Patrick F Chinnery
Journal:  Hum Mol Genet       Date:  2010-05-18       Impact factor: 6.150

10.  Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency.

Authors:  Aida Rodríguez-Nuevo; Angels Díaz-Ramos; Eduard Noguera; Francisco Díaz-Sáez; Xavier Duran; Juan Pablo Muñoz; Montserrat Romero; Natàlia Plana; David Sebastián; Caterina Tezze; Vanina Romanello; Francesc Ribas; Jordi Seco; Evarist Planet; Susan R Doctrow; Javier González; Miquel Borràs; Marc Liesa; Manuel Palacín; Joan Vendrell; Francesc Villarroya; Marco Sandri; Orian Shirihai; Antonio Zorzano
Journal:  EMBO J       Date:  2018-04-09       Impact factor: 11.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.